Elmiron Eye Injury Lawsuit Claims Manufacturers Failed To Properly Test Bladder Pain Drug
Drug makers avoided clinical testing that may have identified the eye injury risks from Elmiron before the drug was placed on the market.
Drug makers avoided clinical testing that may have identified the eye injury risks from Elmiron before the drug was placed on the market.
Monthly case management conferences are scheduled through 2022 in order for lawyers in Elmiron litigation to prepare the first bellwether cases for trial by January 2023.
Series of trials will serve as test cases for hundreds of Elmiron lawsuits alleging users suffered permanent vision problems after taking the bladder drug.